FRANKFURT, March 10 (Reuters) - Bayer now expects a U.S. judge to hold a hearing on May 12 on a $2 billion deal to resolve future legal claims that its widely used weedkiller Roundup causes cancer, a spokesman said on Wednesday.
The German crop chemicals and seeds group had earlier said the matter was due to be heard by March 31. It now expects a court decision on the deal towards the end of the second quarter.
Bayer on Feb. 3 came to terms with plaintiffs’ lawyers in a $2 billion pledge to resolve future claims, as the products in question will remain on the market. That would add $750 million to the total bill of an outline settlement agreed in June 2020, tallied at up to $11 billion at the time.
Some plaintiffs’ lawyers, who have so far opted out of the overall settlement, had lodged objections against the deal on future cases. (Reporting by Patricia Weiss, Writing by Douglas Busvine and Ludwig Burger)